Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers

25 Mar 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Galectins and Cancer Biology
Share to Studies on Chitinases and Chitosanases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35332416
DOI: 10.1007/s10741-022-10231-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkersPMID 35332416Read ↗

A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathySemantic proximity Read ↗

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated CardiomyopathySemantic proximity Read ↗

Role of microRNAs in cardiac remodelling: New insights and future perspectivesSemantic proximity Read ↗

Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.Semantic proximity Read ↗

The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old EntitySemantic proximity Read ↗

Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic CardiomyopathySemantic proximity Read ↗

MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the ArtSemantic proximity Read ↗

Guidelines for the diagnosis and management of hypertrophic cardiomyopathy.Semantic proximity Read ↗

MicroRNAs challenge the status quo of therapeutic targeting.Semantic proximity Read ↗

Unveiling miRNA Biomarkers for Hypertrophic Cardiomyopathy through Integrated Bioinformatics and Machine Learning AnalysisSemantic proximity Read ↗

New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic StrategiesSemantic proximity Read ↗

MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.